From: Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience
Response
Cefepime
Meropenem
Piperacillin/tazobactum
p-valuea
p-valueb
p-valuec
Day 3
20/33 (60.61)
21/33 (63.64)
17/33 (51.52)
0.800
0.319
0.457
Day 7
25/33 (75.76)
22/33 (66.67)
0.284
0.415
0.796